3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Hodgkin Disease
3
Anemia, Refractory, with Excess of Blasts
3
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Interventions
Nivolumab
21
pembrolizumab
18
Ipilimumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
7
trametinib
5
binimetinib
5
Opdualag
5
relatlimab
4
dabrafenib
4
atezolizumab
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
Biopsy
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
aldesleukin
2
X-Rays
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Busulfan
×
30 days
×
Clear all
No trials found.